Latest News

High adverse events with TB prevention in HIV-infected pregnant women


 

FROM CROI 2018

“I think we now need to reweigh the evidence for pros and cons for IPT in pregnancy,” Dr. Gupta concluded.

The study was sponsored the National Institutes of Health. Dr. Gupta reported having nothing to disclose.

SOURCE: Gupta A et al. CROI 2018, Abstract Number 142LB.

Pages

Recommended Reading

HIV diagnosis at home and same-day ART start tied to better outcomes
MDedge Infectious Disease
Raltegravir not associated with IRIS in African trial
MDedge Infectious Disease
‘Clean and sober’ ex-prisoners have better HIV suppression
MDedge Infectious Disease
Looking to increase PrEP uptake
MDedge Infectious Disease
Hospital urine screening reduces TB deaths in HIV+ adults
MDedge Infectious Disease
Dolutegravir-based regimen effective in HIV/TB coinfected
MDedge Infectious Disease
RAPID ART program yields clinical benefits in San Francisco
MDedge Infectious Disease
Some non-AIDS conditions hint at HIV infection in adults
MDedge Infectious Disease
HIV+ dialysis patients: Differential survival by race compared with HIV/HCV coinfection
MDedge Infectious Disease
Efavirenz-based ART may hamper vaginal ring contraception
MDedge Infectious Disease